Pediatric hypophosphatasia: avoid diagnosis missteps!

Author:

Whyte Michael P123ORCID,McAlister William H4,Mack Karen E3,Mumm Steven123ORCID,Madson Katherine L3

Affiliation:

1. Division of Bone and Mineral Diseases , Department of Internal Medicine, ; St. Louis, MO 63110 , United States

2. Washington University School of Medicine at Barnes-Jewish Hospital , Department of Internal Medicine, ; St. Louis, MO 63110 , United States

3. Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children-St. Louis ; St. Louis, MO 63110 , United States

4. Pediatric Radiology Section, Mallinckrodt Institute of Radiology at St. Louis Children’s Hospital, Washington University School of Medicine ; St. Louis, MO 63110 , United States

Abstract

Vignette Hypophosphatasia (HPP) is the dento-osseous disorder caused by deactivating mutation(s) of ALPL, the gene that encodes the “tissue-nonspecific” isoenzyme of alkaline phosphatase (TNSALP). In HPP, 3 natural substrates of cell-surface TNSALP accumulate extracellularly; phosphoethanolamine (PEA), inorganic pyrophosphate (PPi), and pyridoxal 5′-phosphate (PLP). Hypophosphatasemia together with elevated plasma levels of PEA, PPi, and PLP comprise its biochemical signature. PPi can inhibit mineralization and in extracellular excess can impair bone and tooth hardening and perhaps explain weak muscle. Autosomal dominant or autosomal recessive inheritance from among more than 400 mutations of ALPL largely accounts for HPP’s broad-ranging severity, greatest among all skeletal diseases. Pediatric HPP spans life-threatening perinatal and infantile forms, childhood forms, and odonto-HPP selectively featuring premature loss of deciduous teeth. ALPL gene testing and TNSALP supplementation therapy have bolstered familiarity with HPP, but there are new considerations for diagnosis. Herein, diagnosis of a boy’s mild childhood HPP was delayed by missteps involving his medical and dental history, physical examination, radiographic findings, and clinical laboratory studies. We review how pediatric HPP is now identified. Prompt diagnosis while appreciating the broad-ranging severity of HPP underlies the safe and effective management of this inborn-error-of-metabolism.

Funder

Clark and Mildred Cox Inherited Metabolic Bone Disease Research Endowed Fund at the Foundation for Barnes-Jewish Hospital

Shriners Hospitals for Children

Publisher

Oxford University Press (OUP)

Reference10 articles.

1. Hypophosphatasia: enzyme replacement therapy bring new opportunities and new challenges;Whyte;J Bone Miner Res,2017

2. Alkaline phosphatase: discovery and naming of our favorite enzyme;Siller;J Bone Miner Res,2018

3. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B6 metabolism;Whyte;Bone,2024

4. Hyperphosphatemia with Low FGF7 and Normal FGF23 and SFRP4 Levels in the Circulation Characterizes Pediatric Hypophosphatasia;Whyte

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3